Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,221.60
-37.20 (-1.65%)
Oct 21, 2026, 3:29 PM IST
Caplin Point Laboratories Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 22,873 | 21,896 | 19,396 | 16,961 | 14,683 | 12,710 |
Revenue Growth | 15.02% | 12.89% | 14.35% | 15.51% | 15.53% | 19.64% |
Gross Profit Gross Profit Growth | 13,717 | 12,882 | 11,379 | 9,400 | 7,891 | 6,986 |
Operating Income Operating Income Growth | 7,185 | 6,946 | 5,870 | 5,009 | 3,984 | 3,496 |
Net Income Net Income Growth | 6,654 | 6,412 | 5,363 | 4,571 | 3,763 | 2,998 |
Earnings Per Share EPS Growth | 87.29 | 84.11 | 70.25 | 59.90 | 49.18 | 39.26 |
EPS Growth | 17.90% | 19.73% | 17.28% | 21.80% | 25.27% | 23.81% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Rest of The World Rest of The World Growth | 18,063 | 17,338 | 15,830 | 13,807 |
United States of America (USA) United States of America (USA) Growth | 4,810 | 4,534 | 3,545 | 3,134 |
Unallocated Unallocated Growth | - | 1,155 | 964.3 | 669.4 |
Total Total Growth | 22,977 | 23,027 | 20,339 | 17,610 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 10,068 | 9,093 | 8,852 | 7,348 | 6,503 | 5,127 |
Total Debt Total Debt Growth | 46.1 | 46.1 | 50.2 | 19.7 | 54.8 | 21.3 |
Net Cash (Debt) Net Cash Growth | 10,021 | 9,047 | 8,802 | 7,329 | 6,448 | 5,106 |
Net Cash Growth | 11.63% | 2.78% | 20.11% | 13.66% | 26.29% | 19.33% |
Net Cash Per Share Net Cash Per Share Growth | 131.48 | 118.67 | 115.29 | 96.04 | 84.28 | 66.85 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 5,232 | 4,324 | 3,184 | 2,714 | 3,367 |
Capital Expenditures CapEx Growth | - | -2,481 | -1,915 | -1,458 | -1,935 | -911.8 |
Free Cash Flow Free Cash Flow Growth | - | 2,751 | 2,409 | 1,726 | 779 | 2,456 |
Free Cash Flow Growth | - | 14.22% | 39.57% | 121.53% | -68.27% | 25.74% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 59.97% | 58.83% | 58.67% | 55.42% | 53.74% | 54.96% |
Operating Margin | 31.41% | 31.72% | 30.26% | 29.53% | 27.13% | 27.51% |
Pretax Margin | 36.88% | 36.66% | 34.89% | 33.28% | 30.74% | 30.36% |
Profit Margin | 29.09% | 29.29% | 27.65% | 26.95% | 25.62% | 23.59% |
FCF Margin | - | 12.57% | 12.42% | 10.17% | 5.30% | 19.32% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 8.000 | 8.000 | 6.000 | 5.000 | 4.500 | 4.000 |
Dividend Per Share Growth | 33.33% | 33.33% | 20.00% | 11.11% | 12.50% | 33.33% |
Dividend Yield | 0.36% | 0.53% | 0.30% | 0.38% | 0.75% | 0.59% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.38 | 17.84 | 28.38 | 21.89 | 12.04 | 17.18 |
P/FCF Ratio | 61.37 | 41.59 | 63.20 | 57.97 | 58.14 | 20.99 |
PS Ratio | 7.38 | 5.23 | 7.85 | 5.90 | 3.09 | 4.05 |